Pharmabiz

Roche’s phase III FENtrepid study of fenebrutinib meets its primary endpoint of non-inferiority compared to Ocrevus in reducing disability progression in patients with PPMS

Roche’s phase III FENtrepid study of fenebrutinib meets its primary endpoint of non-inferiority compared to Ocrevus in reducing disability progression in patients with PPMS ...
HousingWire

Mortgage rate relief under Warsh may prove elusive, experts say

Kevin Warsh’s nomination as Fed chair raises questions about future rate policy, FOMC unity and mortgage market signals.

Stitching Awareness Into Lives: Sanjeevani Launches ‘The Pink Tag Project’, Turning Everyday Moments Into Life-Saving Reminders

The third edition of Sanjeevani: United Against Cancer – a transformative initiative by Federal Bank Hormis Memorial ...
The Manila Times

Roche’s fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in ...
Taiwan News

Armenia Banking Market Trends, Growth Drivers, and Key Insights for 2033 and Beyond

We are excited to unveil the newest edition of our exhaustive market research report “Armenia Banking Market,” crafted by Report Ocean, a leading provider of industry insights. This report offers a ...

Banco Santander-Chile (BSAC) Q4 2025 Earnings Call Transcript

Good morning, everyone, and welcome to Banco Santander-Chile's Fourth Quarter 2025 Results Webcast and Conference Call. This is Patricia Perez, CFO, and I'm joined today by Cristian Vicuna, Head of ...

F. Hoffmann-La Roche Ltd: Roche's fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple ...

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, OCREVUS, in reduc ...
Scientific Research Publishing

A Digital Accounting Framework for Enhancing Solvency and Financial Evaluation in Non-Bank Financial Institutions: Evidence from Egypt ()

Lotfy, A. (2026) A Digital Accounting Framework for Enhancing Solvency and Financial Evaluation in Non-Bank Financial ...
The Investor

Vietnam’s path to an investment-grade rating

An upgrade to investment-grade would mark a pivotal milestone in Vietnam’s economic trajectory, removing one of the final structural barriers that limits the country’s access to a wider group of ...
Hosted on MSN

Federal Reserve is revisiting some bank regulations, including Basel III endgame, SLR, Powell says

The Federal Reserve is reviewing its bank regulations regarding Basel III endgame, supplemental leverage ratio, merger policy, stress tests Federal Reserve Chair Jerome Powell said on Wednesday. Note ...

Ares Management Corporation (ARES) Presents at Bank of America Financial Services Conference 2026 Transcript

Bank of America Financial Services Conference 2026 February 10, 2026 8:50 AM ESTCompany ParticipantsMichael Arougheti ...

1 Day CoRep, FinRep & Capital Adequacy Online Course: Regulatory Guidance from the PRA/FCA, EBA and Local European Regulators - and UK Financial Reporting Post Brexit

The course offers market opportunities to financial institutions by enhancing their understanding of COREP and FINREP frameworks, improving compliance, data management, reporting accuracy, and risk ...